Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
321
6 regions32 stories14 publishers13 countries
Top story
Germany's Cannabis Act (CanG) advances after first Bundestag parliamentary debate
Germany’s Cannabis Act (CanG) took another important step forward this week after the first parliamentary debate was held in the Bundestag (German Parliament).
Business of CannabisDERegulation
- 01
New York cannabis regulators extend licence application window
Business of CannabisUSRegulation
- 02
Israeli cannabis companies navigate challenges amid Hamas conflict
Business of CannabisILBusiness & Investment
Europe
6 stories- France's health minister promises continued access to medical cannabis
Business of CannabisFRMedical
- Exploring medical cannabis in Belgium: Insights from Clinical Cannabinology
Business of CannabisBEMedical
- Denmark's medical cannabis pilot sees 90% patient growth in past year
Business of CannabisDKMedical
- Ukraine's medical cannabis legalisation bid clears another hurdle
Cannabis HealthUARegulation
- First UK-grown cannabis-based medicines expected by end of 2023
Cannabis HealthGBMedical
- Belfast to host Ireland's first medical cannabis production facility next year
thejournal.ieIEBusiness & Investment
United States
6 stories- Four new dispensaries set to open in New York following CAURD delay
Business of CannabisUSAdult-use
- New York's OCM to hold workshops supporting cannabis licence applications
Business of CannabisUSRegulation
- Colorado's legal cannabis sales surpass US$15 billion amid monthly slowdown
Business of CannabisUSBusiness & Investment
- Ohio residents begin early voting on state's adult-use cannabis legalisation
Business of CannabisUSAdult-use
- Oregon's cannabis associations vote to merge and strengthen state industry
Business of CannabisUSBusiness & Investment
- Maryland judge halts ban on CBD shops selling intoxicating hemp-derived products
Business of CannabisUSHemp & CBD
Canada
6 stories- Cannabis legalisation in Canada brings societal benefits yet mixed public health impact
Cannabis HealthCARegulation
- Tilray Medical supports clinical trial of cannabis in glioblastoma cancer treatment
GlobeNewswireCAHealth & Science
- Verano Holdings begins trading on Canada's Neo Exchange Inc
Business of CannabisCABusiness & Investment
- Toronto's GrowerIQ receives over C$1 million in Canadian government funding
MondaqCABusiness & Investment
- Avant Brands Inc. reports third quarter revenue of C$6.5 million
BenzingaCABusiness & Investment
- Manitoba judge upholds ban on non-medical homegrown cannabis
CBCCARegulation
LATAM & Caribbean
4 stories- Project to legalise cannabis for adult use in Colombia overcomes further debate
SechatCOAdult-use
- Former Anvisa director discusses how legal actions discredit cannabis treatment
SechatBRMedical
- João Pessoa City Council approves medicinal cannabis policy bill in Brazil
SechatBRRegulation
- Brazil's Anvisa to cultivate five thousand cannabis plants for genetic bank
SechatBRBusiness & Investment
Africa & Middle East
2 stories- InterCure Ltd delivers update on security situation in Israel
StreetInsiderILBusiness & Investment
- Israel's Ministry of Health grants concessions for medical cannabis patients
Cannabis Magazine (Israel)ILMedical
Oceania
4 stories- Sydney's Endoca Australia rebrands to Aura Therapeutics
CannabizAUBusiness & Investment
- Victorian Parliament approves medicinal cannabis driving trial research
High TimesAUHealth & Science
- New Zealand's Medsafe reclassifies CBD to pharmacist-only medicine
nzdoctor.co.nzNZRegulation
- Bioxyne subsidiary Breathe Life Sciences imports $3.2 million cannabis flower to Australia
StockheadAUBusiness & Investment
Stocks
- Weekly stock report
Business of CannabisBusiness & Investment
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report